du Bois W - Search Results

1

SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma.

Kim YI, Tseng YC, Ayaz G, Wang S, Yan H, du Bois W, Yang H, Zhen T, Lee MP, Liu P, Kaplan RN, Huang J. Kim YI, et al. Among authors: du bois w. Cell Biosci. 2023 Jul 25;13(1):136. doi: 10.1186/s13578-023-01088-2. Cell Biosci. 2023. PMID: 37491298 Free PMC article.

2

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma.

Peat TJ, Gaikwad SM, Dubois W, Gyabaah-Kessie N, Zhang S, Gorjifard S, Phyo Z, Andres M, Hughitt VK, Simpson RM, Miller MA, Girvin AT, Taylor A, Williams D, D'Antonio N, Zhang Y, Rajagopalan A, Flietner E, Wilson K, Zhang X, Shinn P, Klumpp-Thomas C, McKnight C, Itkin Z, Chen L, Kazandijian D, Zhang J, Michalowski AM, Simmons JK, Keats J, Thomas CJ, Mock BA. Peat TJ, et al. Cancer Lett. 2023 Aug 1;568:216284. doi: 10.1016/j.canlet.2023.216284. Epub 2023 Jun 24. Cancer Lett. 2023. PMID: 37356470

3

Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer.

Malik N, Kim YI, Yan H, Tseng YC, du Bois W, Ayaz G, Tran AD, Vera-Ramirez L, Yang H, Michalowski AM, Kruhlak M, Lee M, Hunter KW, Huang J. Malik N, et al. Among authors: du bois w. Cancer Res. 2023 Apr 14;83(8):1280-1298. doi: 10.1158/0008-5472.CAN-22-2525. Cancer Res. 2023. PMID: 36799863 Free PMC article.

4

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.

Malik N, Yan H, Yang HH, Ayaz G, DuBois W, Tseng YC, Kim YI, Jiang S, Liu C, Lee M, Huang J. Malik N, et al. PLoS Genet. 2021 May 4;17(5):e1009553. doi: 10.1371/journal.pgen.1009553. eCollection 2021 May. PLoS Genet. 2021. PMID: 33945523 Free PMC article.

5

Mouse tumor susceptibility genes identify drug combinations for multiple myeloma.

Zhang S, DuBois W, Zhang K, Simmons JK, Hughitt VK, Gorjifard S, Gaikwad S, Peat TJ, Mock BA. Zhang S, et al. J Cancer Metastasis Treat. 2020;6:21. doi: 10.20517/2394-4722.2020.40. Epub 2020 Jul 26. J Cancer Metastasis Treat. 2020. PMID: 32923678 Free PMC article.

6

The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility.

Zhang S, Shi W, Ramsay ES, Bliskovsky V, Eiden AM, Connors D, Steinsaltz M, DuBois W, Mock BA. Zhang S, et al. J Biol Chem. 2019 Nov 8;294(45):16756-16764. doi: 10.1074/jbc.RA119.009779. Epub 2019 Sep 23. J Biol Chem. 2019. PMID: 31548308 Free PMC article.

7

3'Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations.

Kovalchuk AL, Sakai T, Qi CF, Du Bois W, Dunnick WA, Cogné M, Morse HC 3rd. Kovalchuk AL, et al. Among authors: du bois w. Oncotarget. 2018 Oct 2;9(77):34528-34542. doi: 10.18632/oncotarget.26160. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349647 Free PMC article.

8

ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells.

Wang H, Gonzalez-Garcia I, Traba J, Jain S, Conteh S, Shin DM, Qi C, Gao Y, Sun J, Kang S, Abbasi S, Naghashfar Z, Yoon J, DuBois W, Kovalchuk AL, Sack MN, Duffy P, Morse HC 3rd. Wang H, et al. Sci Rep. 2017 Dec 19;7(1):17867. doi: 10.1038/s41598-017-18028-z. Sci Rep. 2017. PMID: 29259245 Free PMC article.

9

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells.

Sintes J, Gentile M, Zhang S, Garcia-Carmona Y, Magri G, Cassis L, Segura-Garzón D, Ciociola A, Grasset EK, Bascones S, Comerma L, Pybus M, Lligé D, Puga I, Gutzeit C, He B, DuBois W, Crespo M, Pascual J, Mensa A, Aróstegui JI, Juan M, Yagüe J, Serrano S, Lloreta J, Meffre E, Hahne M, Cunningham-Rundles C, Mock BA, Cerutti A. Sintes J, et al. Nat Commun. 2017 Nov 13;8(1):1462. doi: 10.1038/s41467-017-01602-4. Nat Commun. 2017. PMID: 29133782 Free PMC article.

10

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation.

Simmons JK, Michalowski AM, Gamache BJ, DuBois W, Patel J, Zhang K, Gary J, Zhang S, Gaikwad S, Connors D, Watson N, Leon E, Chen JQ, Kuehl WM, Lee MP, Zingone A, Landgren O, Ordentlich P, Huang J, Mock BA. Simmons JK, et al. Mol Cancer Ther. 2017 Sep;16(9):2008-2021. doi: 10.1158/1535-7163.MCT-17-0171. Epub 2017 May 18. Mol Cancer Ther. 2017. PMID: 28522584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page